Cervical gland area as an ultrasonographic marker for preterm delivery

2006 ◽  
Vol 93 (3) ◽  
pp. 214-219 ◽  
Author(s):  
C.R. Pires ◽  
A.F. Moron ◽  
R. Mattar ◽  
A.L.D. Diniz ◽  
S.G.A. Andrade ◽  
...  
2009 ◽  
Vol 68 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Hirobumi Asakura ◽  
Takehiko Fukami ◽  
Ryuhei Kurashina ◽  
Naoko Tateyama ◽  
Daisuke Doi ◽  
...  

2011 ◽  
Vol 285 (1) ◽  
pp. 255-258 ◽  
Author(s):  
Nargess Afzali ◽  
Marzieh Mohajeri ◽  
Abdolreza Malek ◽  
Atefeh Alamatian

2017 ◽  
Vol 15 (11) ◽  
pp. 729-734
Author(s):  
Vajiheh Marsoosi ◽  
Reihaneh Pirjani ◽  
Mohamad Asghari Jafarabadi ◽  
Mina Mashhadian ◽  
Saeedeh Ziaee ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Resul Arisoy ◽  
Murat Yayla

Preterm delivery (PTD), defined as birth before 37 completed weeks of gestation, is the leading cause of perinatal morbidity and mortality. Evaluation of the cervical morphology and biometry with transvaginal ultrasonography at 16–24 weeks of gestation is a useful tool to predict the risk of preterm birth in low- and high-risk singleton pregnancies. For instance, a sonographic cervical length (CL) > 30 mm and present cervical gland area have a 96-97% negative predictive value for preterm delivery at <37 weeks. Available evidence supports the use of progesterone to women with cervical length ≤25 mm, irrespective of other risk factors. In women with prior spontaneous PTD with asymptomatic cervical shortening (CL ≤ 25 mm), prophylactic cerclage procedure must be performed and weekly to every two weeks follow-up is essential. This article reviews the evidence in support of the clinical introduction of transvaginal sonography for both the prediction and management of spontaneous preterm labour.


Sign in / Sign up

Export Citation Format

Share Document